Ajanta Pharma will host one-on-one meetings with analysts and institutional investors on two dates in September 2026. The sessions are scheduled for September 16 in New Delhi and September 28 in Mumbai.

The company disclosed the schedule pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Gaurang Shah, Senior Vice President and Company Secretary, confirmed the dates on August 31, 2026.

Meeting Schedule

Both engagements are classified as one-on-one meetings. The company noted that the schedule is subject to change due to exigencies on either side.

Discussion Scope

Ajanta Pharma confirmed that discussions during these meetings will be strictly based on already published information. The firm did not disclose any new financial data or operational updates in this intimation.

Ajanta Pharma promoter Aayush Agrawal pledged 9,20,000 equity shares of the company to 360 One Prime Ltd on August 21, 2026. The move was made to provide additional security, following the release of a pledge on 9,76,000 shares on August 19, 2026, for loan repayment.

The disclosure was filed with the Bombay Stock Exchange and National Stock Exchange on August 27, 2026, under Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Pledge Transaction Details

Aayush Agrawal, acting as trustee for the Aayush Agrawal Trust, executed two separate encumbrance events within a week. The initial release of shares reduced the pledged holding with RBL Bank Ltd, while the subsequent creation increased exposure with 360 One Prime Ltd.

Promoter Holding Structure

As on the reporting date, the total promoter holding in Ajanta Pharma stands at 4,58,03,373 shares, representing 36.64% of the total share capital. This figure aggregates holdings across various entities and individuals associated with the promoter group.

The Aayush Agrawal Trust holds 1,41,12,924 shares (11.29%). Post-transaction, 1,34,76,924 shares (10.79%) from this block remain encumbered. Other significant promoter entities include Yogesh M Agrawal Trust and Rajesh M Agrawal Trust, each holding 1,80,78,147 shares (14.47%), none of which are currently encumbered.

What the Numbers Show

The net change in pledged shares for the Aayush Agrawal Trust is a reduction of 56,000 shares. However, the counterparty shifted from RBL Bank Ltd to 360 One Prime Ltd. This indicates a restructuring of collateral arrangements rather than a simple deleveraging event, as new debt or security requirements were met by re-pledging nearly all released shares.